This information was published on 2025-04-28T09:26 for IP Right Filed Published.
| Field | Value |
| (210) | 2543180 |
| (220) |
28 Apr 2025
|
| (300) |
US, 25 Oct 2024, 98/820,820
|
| (511) (510) |
Class 5
Pharmaceuticals for the treatment of cancers and tumors; medical preparations, namely, vaccines, antigens, immunotherapeutic agents for the treatment and prevention of cancers and tumors Class 42 Scientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, vaccination, and oncology; industrial research in the fields of genetics, immunotherapy, vaccination, and oncology; medical and pharmacological research services; medical research services; research and development of vaccines and medicines; research and development of antigenic and immunotherapeutic agents |
| (540) | DARK TARGET |
| (550) | Word |
| (730) |
Rybodyn, Inc.
|
| (750) |
Pizzeys Patent and Trade Mark Attorneys Pty Ltd
|
Find out more about publications on the About page.